Oral 17β-estradiol and medroxyprogesterone acetate therapy in postmenopausal women increases HDL particle size

Plasma Triglyceride Level is a Risk Factor for Cardiovascular Disease Independent of High-Density Lipoprotein Cholesterol Level: A Metaanalysis of Population-Based Prospective Studies

1996 • 2,037 citations

Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies

1996 • 1,658 citations

Effects of Postmenopausal Estrogen Replacement on the Concentrations and Metabolism of Plasma Lipoproteins

1991 • 1,158 citations

Association of Small Low-Density Lipoprotein Particles With the Incidence of Coronary Artery Disease in Men and Women

1996 • 826 citations

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1995 • 602 citations

Development of a Proton Nuclear Magnetic Resonance Spectroscopic Method for Determining Plasma Lipoprotein Concentrations and Subspecies Distributions from a Single, Rapid Measurement

1992 • 427 citations

Handbook of Lipoprotein Testing

2001 • 366 citations

Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy.

2002 • 352 citations

Relation of Lipoprotein Subclasses as Measured by Proton Nuclear Magnetic Resonance Spectroscopy to Coronary Artery Disease

1998 • 347 citations

Change in LDL particle size is associated with change in plasma triglyceride concentration.

1992 • 280 citations

Differences in Low Density Lipoprotein Subfractions and Apolipoproteins in Premenopausal and Postmenopausal Women*

1988 • 263 citations

High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients.

1991 • 260 citations

Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease

1991 • 207 citations

Lipoprotein, apolipoprotein, and lipolytic enzyme changes following estrogen administration in postmenopausal women.

1989 • 187 citations

Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women

1996 • 187 citations

Characterization of low-density lipoprotein subclasses

1994 • 174 citations

Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women. The Menopause Study Group.

1994 • 167 citations

Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes

1996 • 151 citations

Differences in LDL subspecies involve alterations in lipid composition and conformational changes in apolipoprotein B

1996 • 144 citations

Cryopreservation with sucrose maintains normal physical and biological properties of human plasma low density lipoproteins.

1992 • 140 citations

Handbook of Lipoprotein Testing

1998 • 139 citations

High density lipoprotein subfractions in non-insulin-dependent diabetes mellitus and coronary artery disease.

1995 • 136 citations

Effects of postmenopausal hormone replacement with oral and transdermal estrogen on high density lipoprotein metabolism.

1994 • 134 citations

Effect of Estrogen on Very Low Density Lipoprotein and Low Density Lipoprotein Subclass Metabolism in Postmenopausal Women¹

1997 • 128 citations

Effect of Postmenopausal Estrogen Replacement on Plasma Lp(a) Lipoprotein Concentrations

1994 • 116 citations

Effects of estrogen replacement on plasma lipoproteins and apolipoproteins in postmenopausal, dyslipidemic women

1992 • 105 citations

Effect of Estrogen on Very Low Density Lipoprotein and Low Density Lipoprotein Subclass Metabolism in Postmenopausal Women

1997 • 74 citations

Effect of 17β-Estradiol on Plasma Lipids and LDL Oxidation in Postmenopausal Women With Type II Diabetes Mellitus

1997 • 73 citations

Hepatic lipase activity influences high density lipoprotein subclass distribution in normotriglyceridemic men: genetic and pharmacological evidence

1999 • 73 citations

Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women

1995 • 64 citations

Unusual high-density lipoprotein subclass distribution during late pregnancy

1993 • 63 citations

Associations of age, adiposity, alcohol intake, menstrual status, and estrogen therapy with high-density lipoprotein subclasses.

1993 • 57 citations

Changes in the low-density lipoprotein profile during 17β-estradiol-dydrogesterone therapy in postmenopausal women

1994 • 47 citations

Effect of estrogen on the size of low-density lipoprotein particles in postmenopausal women

1997 • 41 citations

Estrogen replacement decreases the level of antibodies against oxidized low-density lipoprotein in postmenopausal women with coronary heart disease

1998 • 35 citations

Effects of postmenopausal estrogen/progestin replacement therapy on LDL particles; comparison of transdermal and oral treatment regimens

1996 • 31 citations

Effect of postmenopausal estrogen replacement on plasma Lp(a) lipoprotein concentrations

1994 • 29 citations

Effects of Tourniquet Technique, Order of Draw, and Sample Storage on Plasma Fibrinogen

1998 • 21 citations

High-density lipoprotein: Relations to metabolic parameters and severity of coronary artery disease

1996 • 20 citations

Hormonal, metabolic, and cellular influences on cardiovascular disease in women

1997 • 19 citations

Effects of tourniquet application on plasma viscosity measurements

1998 • 15 citations

Hormonal, Metabolic, and Cellular Influences on Cardiovascular Disease in Women

1998 • 13 citations

Impact of combined hormone replacement therapy on serum lipid metabolism: New aspects

1997 • 5 citations

Cited By (0)

Loading...